首页> 外文期刊>Acta Poloniae Pharmaceutica: Durg Research >Interaction between different doses of simvastatin after two-week administration and metoprolol injection on the heart rate in normocholesterolemic rats.
【24h】

Interaction between different doses of simvastatin after two-week administration and metoprolol injection on the heart rate in normocholesterolemic rats.

机译:在正常胆固醇血症大鼠中,两周给药后不同剂量的辛伐他汀与美托洛尔对心率的相互作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Heart rate slowing is the beneficial effect after beta-blocker administration in cardiac heart failure and ischemic heart disease. However, bradycardia and another cardiac disturbances after beta-blockers therapy are the most dangerous side effects. Many patients with cardiovascular diseases receiving beta-blockers are recommended to statin therapy, as well. Previous study showed that statins may desensitize beta-adrenergic signaling, in cardiac myocytes via reduction of isoprenylation of G-protein gamma-subunits. The aim of the study was to evaluate the influence of simvastatin at different doses and metoprolol injection on the heart rate in normocholesterolemic rats. The experiments were performed in Wistar rats, outbred males. Simvastatin at 1, 10 or 20 mg/kg or vehicle (0.2% methylcellulose) were given intragastrically during two-week period. After two week administration of simvastatin, rats were injected intraperitoneally with metoprolol at 5 mg/kg b.w. The heart rate signals were provided by Isotec pressure transducer connected to a direct current bridge amplifier and catheter was implanted into the right carotid artery. No changes in the baseline heart rate among all groups of the animals were observed. Metoprolol administration caused statistically significant decrease in heart rate in all groups of rats. In the control group, after metoprolol administration heart rate slowed down to 83.11 +/- 1.11% (p < 0.05) of the baseline values, in group receiving simvastatin at 1 mg/kg b.w. 82.72 +/- 5.49% (p < 0.05), in group receiving simvastatin at 10 mg/kg b.w. 85.13 +/- 4.75 (p <0.05) and in group receiving simvastatin at 20 mg/kg b.w. 85.13 +/- 4,75% (p < 0.05) of the baseline values. No significant decrease in heart rate in the control group as compared to groups receiving simvastatin in different doses was observed. No significant changes among animals receiving simvastatin in different doses were observed, as well. CONCLUSION: Two week administration of simvastatin in different doses to normocholesterolaemic rats does not modify metoprolol-induced depressing influence on the heart rate.
机译:在心力衰竭和缺血性心脏病中,使用β受体阻滞剂后,心率减慢是有益的作用。但是,β受体阻滞剂治疗后的心动过缓和其他心脏疾病是最危险的副作用。许多接受β受体阻滞剂治疗的心血管疾病患者也建议使用他汀类药物治疗。先前的研究表明,他汀类药物可能通过减少G蛋白γ亚基的异戊二烯化作用使心肌细胞中的β-肾上腺素信号转导不敏感。该研究的目的是评估不同剂量的辛伐他汀和美托洛尔注射液对正常胆固醇血症大鼠心率的影响。实验是在Wistar大鼠(近交雄性)中进行的。在两周内通过胃内给予辛伐他汀1、10或20 mg / kg或赋形剂(0.2%甲基纤维素)。辛伐他汀给药两周后,给大鼠腹膜内注射美托洛尔,剂量为5 mg / kgb.w。由连接到直流电桥放大器的Isotec压力传感器提供心率信号,并将导管植入右颈动脉。在所有动物组中均未观察到基线心率变化。美托洛尔的给药在所有组的大鼠中均引起心率的统计学显着降低。在对照组中,在接受辛伐他汀1 mg / kg b.w的组中,美托洛尔给药后,心率减慢至基线值的83.11 +/- 1.11%(p <0.05)。接受辛伐他汀10 mg / kg体重的组中82.72 +/- 5.49%(p <0.05)。 85.13 +/- 4.75(p <0.05),接受辛伐他汀20 mg / kg b.w的组。基线值的85.13 +/- 4,75%(p <0.05)。与接受不同剂量辛伐他汀的组相比,对照组的心率没有明显下降。在接受辛伐他汀的不同剂量的动物之间也没有观察到显着变化。结论:正常胆固醇血症大鼠以不同剂量服用辛伐他汀两周并不能改变美托洛尔对心率的抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号